DALLA COSTA, GLORIA
 Distribuzione geografica
Continente #
EU - Europa 1.903
AS - Asia 1.133
NA - Nord America 863
SA - Sud America 227
AF - Africa 24
OC - Oceania 2
Totale 4.152
Nazione #
RU - Federazione Russa 1.301
US - Stati Uniti d'America 819
SG - Singapore 444
CN - Cina 348
SE - Svezia 222
BR - Brasile 187
HK - Hong Kong 129
VN - Vietnam 102
DE - Germania 69
IT - Italia 69
FR - Francia 67
GB - Regno Unito 47
FI - Finlandia 33
IE - Irlanda 25
IN - India 25
CA - Canada 23
PL - Polonia 22
AT - Austria 21
IQ - Iraq 14
JP - Giappone 14
MX - Messico 14
AR - Argentina 13
ES - Italia 12
BD - Bangladesh 11
ZA - Sudafrica 11
TR - Turchia 9
EC - Ecuador 8
ID - Indonesia 8
MA - Marocco 5
NL - Olanda 5
PY - Paraguay 5
CL - Cile 4
CO - Colombia 4
PK - Pakistan 4
AL - Albania 3
IR - Iran 3
SA - Arabia Saudita 3
TN - Tunisia 3
UZ - Uzbekistan 3
VE - Venezuela 3
DO - Repubblica Dominicana 2
EG - Egitto 2
HN - Honduras 2
IL - Israele 2
KG - Kirghizistan 2
PE - Perù 2
PH - Filippine 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AO - Angola 1
AU - Australia 1
AZ - Azerbaigian 1
BB - Barbados 1
DK - Danimarca 1
DZ - Algeria 1
GR - Grecia 1
GY - Guiana 1
JM - Giamaica 1
KI - Kiribati 1
KR - Corea 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
LU - Lussemburgo 1
ML - Mali 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
QA - Qatar 1
RO - Romania 1
UA - Ucraina 1
Totale 4.152
Città #
Singapore 210
Moscow 184
Ashburn 145
Hong Kong 127
Dallas 79
San Jose 79
Shanghai 66
Hefei 53
Beijing 50
Lauterbourg 47
Lawrence 46
Princeton 46
New York 36
Los Angeles 32
Hanoi 28
Ho Chi Minh City 26
Dublin 25
Helsinki 24
São Paulo 24
Munich 23
Warsaw 18
Boardman 16
Milan 15
Manchester 14
Tokyo 14
Nuremberg 13
Santa Clara 13
Vienna 13
Orem 12
Frankfurt am Main 11
Montreal 11
Poplar 11
Atlanta 10
Boston 10
Brooklyn 10
Chennai 9
Houston 9
Stockholm 9
Johannesburg 8
London 8
Rio de Janeiro 8
Guangzhou 7
Mexico City 7
Cesano Boscone 6
Chicago 6
Da Nang 6
Denver 6
Haiphong 6
Hải Dương 6
San Francisco 6
Turku 6
Ankara 5
Council Bluffs 5
Curitiba 5
Phoenix 5
Tianjin 5
Baghdad 4
Brasília 4
Mumbai 4
Pisa 4
Seattle 4
Toronto 4
Belo Horizonte 3
Bengaluru 3
Bergamo 3
Biên Hòa 3
Guayaquil 3
Lappeenranta 3
Salvador 3
Secaucus 3
Sulaymaniyah 3
Wroclaw 3
Agadir 2
Annapolis 2
Assago 2
Bishkek 2
Campinas 2
Dammam 2
Florence 2
Guarapuava 2
Guarulhos 2
Hangzhou 2
Hortolândia 2
Itaquaquecetuba 2
Jacksonville 2
Jakarta 2
João Pessoa 2
Juiz de Fora 2
Kish 2
La Florida 2
Marrakesh 2
Miami 2
Mogi das Cruzes 2
New Delhi 2
Nova Iguaçu 2
Paris 2
Pará de Minas 2
Philadelphia 2
Praia Grande 2
Quito 2
Totale 1.789
Nome #
Using smartphones and wearable devices to monitor behavioral changes during COVID-19 555
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicantre study 115
Assessing the role of innovative therapeutic paradigm on multiple sclerosis treatment response 112
Bilateral Repetitive Transcranial Magnetic Stimulation With the H-Coil in Parkinson's Disease: A Randomized, Sham-Controlled Study 111
Machine learning-driven diagnosis of multiple sclerosis from whole blood transcriptomics 98
Basal vitamin D levels and disease activity in multiple sclerosis patients treated with fingolimod 96
Repetitive Transcranial Magnetic Stimulation With H-Coil in Alzheimer's Disease: A Double-Blind, Placebo-Controlled Pilot Study 91
Caesarean section and infant formula feeding are associated with an earlier age of onset of multiple sclerosis 90
Assessing seasonal dynamics of Guillain-Barré syndrome with search engine query data 87
CSF extracellular vesicles and risk of disease activity after a first demyelinating event 87
Clinical significance of the number of oligoclonal bands in patients with clinically isolated syndromes. 86
Disease-modifying treatments modulate myeloid cells in multiple sclerosis patients 86
Subclinical anterior optic pathway involvement in early multiple sclerosis and clinically isolated syndromes 86
Free Light Chains and Intrathecal B Cells Activity in Multiple Sclerosis: A Prospective Study and Meta-Analysis 85
Dysregulation of MS risk genes and pathways at distinct stages of disease 83
The Danger of Walking with Socks: Evidence from Kinematic Analysis in People with Progressive Multiple Sclerosis 83
Fifteen years of wireless sensors for balance assessment in neurological disorders 82
Neutrophil-to-lymphocyte ratio: a marker of neuro-inflammation in multiple sclerosis? 81
Performance of the 2017 and 2010 Revised McDonald Criteria in Predicting MS Diagnosis After a Clinically Isolated Syndrome: A MAGNIMS Study 81
High frequency of intestinal TH17 cells correlates with microbiota alterations and disease activity in multiple sclerosis 80
From neuroimaging to clinical setting: What have we learned from migraine pain? 77
Digital epidemiology confirms a latitude gradient of MS in France 76
Comparative effectiveness of dimethylfumarate and fingolimod in an Italian monocentric cohort of relapsing remitting multiple sclerosis patients 71
Early clinical and mri predictors of long-term disability in pediatric multiple sclerosis patients 69
Platelet glutamate uptake and Th1 cells inversely correlate in relapsing/remitting and in progressive multiple sclerosis 69
Intracortical motor conduction is associated with hand dexterity in progressive multiple sclerosis 68
LETTER RE: The contemporary spectrum of multiple sclerosis misdiagnosis: A multicenter study 64
Smart watch, smarter EDSS: Improving disability assessment in multiple sclerosis clinical practice 64
Multiple biomarkers improve the prediction of multiple sclerosis in clinically isolated syndromes 62
MiR-125a-3p timely inhibits oligodendroglial maturation and is pathologically up-regulated in human multiple sclerosis 62
Refractory migraine: the role of the physician in assessment and treatment of a problematic disease 61
Parry Romberg Syndrome associated with chronic facial pain. 59
Walking-related digital mobility outcomes as clinical trial endpoint measures: Protocol for a scoping review 59
Loss of circulating CD8+ CD161high T cells in primary progressive multiple sclerosis 58
Vitamin D levels and risk of developing multiple sclerosis 57
Prognostic value of serum neurofilaments in patients with clinically isolated syndromes 57
Opinion & special articles: professionalism in neurology. Maintaining patient rapport in a world of EMR. 56
Severe disease activity in a patient with multiple sclerosis after daclizumab discontinuation 56
Vitamin D levels and risk of multiple sclerosis in patients with clinically isolated syndrome 54
Recurrent disease-activity rebound in a patient with multiple sclerosis after natalizumab discontinuations for pregnancy planning. 54
Serum neurofilaments increase at progressive multifocal leukoencephalopathy onset in natalizumab-treated multiple sclerosis patients 53
The Communication of Multiple Sclerosis Diagnosis: The Patients' Perspective 53
Real-time assessment of COVID-19 prevalence among multiple sclerosis patients: a multicenter European study 53
Comparison of the 2017 and 2010 revisions of the mcdonald criteria in patients with cis suggestive of ms: a multicentre magnims study 53
Individual risk of multiple sclerosis in clinically isolated syndromes: a multicenter prospective Italian study 52
Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome 52
Comparison of the 2017 and 2010 Revisions of the McDonald Criteria in Patients with CIS Suggestive of MS: A Multicentre MAGNIMS Study 51
Individual risk of multiple sclerosis in clinically isolated syndromes: a multicenter prospective Italian study 51
Prognostic Value of Vitamin D in Clinically Isolated Syndromes (CIS) 48
Reply to “Serum Neurofilaments as Candidate Biomarkers of Natalizumab Progressive Multifocal Leukoencephalopathy” 47
Overcoming recruitment challenges in patients with multiple sclerosis: Results from an Italian survey. 46
Progressive ataxia in a natalizumab-treated multiple sclerosis patient: the dark side of JC virus infection. 42
Migralepsy: a new case confirming the existence of this migraine complication and proposing therapy 42
Neurofilament light biomarkers in MS: Effects of extended natalizumab dosing 26
A wearable device perspective on the standard definitions of disability progression in multiple sclerosis 5
Assessing disease progression and treatment response in progressive multiple sclerosis 3
Neuroaxonal damage in natalizumab-treated MS patients: The role of JCV antibody titres 2
An overview on disease modifying and symptomatic drug treatments for multiple sclerosis 2
null 1
null 1
null 1
null 1
Totale 4.213
Categoria #
all - tutte 22.644
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.644


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 0 0 0 0 0 1 0
2021/202264 0 0 0 30 2 3 5 4 5 0 0 15
2022/2023331 115 84 27 0 0 38 23 30 13 0 1 0
2023/2024615 0 2 29 18 19 14 5 18 1 5 6 498
2024/2025734 76 25 9 16 32 47 115 67 121 53 64 109
2025/20262.424 206 163 114 399 202 108 211 219 699 103 0 0
Totale 4.213